New Oral Treatment for Multiple Sclerosis (CBS2 News)

6/17/2013

Source: CBS2 News


Dr. Karen Blitz, director of North Shore-LIJ's Multiple Sclerosis Center, discusses an oral treatment that may help patients with a certain type of MS known as relapsing remitting multiple sclerosis.Tecfidera, a newly FDA-approved drug, has few side effects and reduces the frequency of attacks.

View the video.